The blockchain solution aims to make it easier for researchers and physicians to track and manage user consent for individual studies and medical trials. Participants may withdraw consent from studies at all times.
User consent updates are recorded in real time and on an immutable, transparent record. The decentralized ledger uses Bitfury’s existing blockchain Exonum. The blockchain can be used as a data management system and as an add-on to an existing digital system for storing user consent, according to the report.
The new product is HIPAA-compliant and complies with the General Data Protection Regulation.
“The new blockchain solution will strengthen the process of collecting data and researching medical conditions, which could offer far-reaching benefits to people all over the world,” Bitfury CEO Valery Vavilov said, according to CoinGeek.
More articles on health IT:
Blockchain to emerge in healthcare in 5 to 10 years
Department of Homeland Security reissues cyber warning on medical devices
AI teaches physicians to be more empathetic
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
